Selank (also known as TP-7) is a synthetic seven-amino-acid peptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed in Russia at the Institute of Molecular Genetics of the Russian Academy of Sciences by extending the endogenous tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro “glyproline” tail. This modification significantly improves stability against enzymatic degradation, enabling practical research applications via intranasal or other laboratory routes. In Russia, Selank is registered as a 0.15% nasal-drop medicine indicated for anxiety states and the prevention and treatment of stress disorders. Outside Russia it is available exclusively as a research chemical and is not approved by the FDA or other major Western regulatory agencies for any human use.
The most studied aspect of Selank is its anxiolytic profile. Small comparative clinical trials conducted in Russia reported that Selank produced anxiety-reducing effects comparable to benzodiazepines such as medazepam and phenazepam in patients with generalized anxiety or neurasthenia, while appearing to avoid typical benzodiazepine side effects such as sedation, cognitive dulling, muscle relaxation, and dependence. Additional research has explored mild nootropic (cognitive-supporting) and anti-asthenic (anti-fatigue) properties, as well as potential immunomodulatory activity inherited from its tuftsin parent structure. Preclinical work has also examined effects on learning, memory under stress, and neuroprotective markers.
Mechanistically, Selank does not act as a classic receptor agonist or benzodiazepine-site binder. Published studies describe several complementary pathways: positive allosteric-like modulation and altered gene expression of GABA-A receptor subunits, inhibition of enkephalin-degrading enzymes (which prolongs the action of the body’s own enkephalins), shifts in monoamine (serotonin and dopamine) turnover, and upregulation of brain-derived neurotrophic factor (BDNF) in certain brain regions. These multi-target actions help explain the observed combination of calming effects with preserved or even supported cognitive function in research models.
For laboratories and researchers investigating peptide-based approaches to anxiety, stress resilience, or neuroimmune signaling, high-purity Selank offers a well-characterized research tool. Reputable suppliers provide lyophilized peptide with third-party HPLC verification (typically ≥98–99% purity), batch-specific Certificates of Analysis, and clear research-only labeling. Whether your work focuses on GABAergic gene expression, enkephalin metabolism, comparative anxiolytic screening, or peptide stability studies, research-grade Selank delivers consistent material backed by rigorous quality controls. Always handle peptides according to institutional biosafety protocols and applicable regulations. Explore our selection of laboratory-tested Selank and advance your research into this distinctive Russian-developed heptapeptide.





Reviews
There are no reviews yet.